About Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia
During the past decade, Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
2015-11-13
2023-04-30
Active, not recruiting
126
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis
2020-08-10
2028-02-12
Recruiting
252
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia
According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia" are
"Lupus Nephritis" (2 trials). Many other conditions were trialed in "Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia" in a lesser frequency.
Clinical Trials Intervention Types at Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia
Most popular intervention types in "Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Methylprednisolone" (2 trials), "Obinutuzumab" (2 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "Acetaminophen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia
The vast majority of trials in "Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia" are
2 trials for "All" genders.
Clinical Trials Status at Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia
Currently, there are NaN active trials in "Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".